Literature DB >> 28341694

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor and NaCl transport mechanisms in the renal distal nephron.

Shigeru Shibata1,2.   

Abstract

A key role of aldosterone and mineralocorticoid receptor is to regulate fluid volume and K+ homeostasis in the body by acting on the renal distal nephron. Global responses of the kidney to elevated aldosterone levels are determined by the coordinate action of different constituent tubule cells, including principal cells, intercalated cells and distal convoluted tubule cells. Recent studies on genetic mutations causing aldosterone overproduction have identified the molecules involved in aldosterone biosynthesis in the adrenal gland, and there is also increasing evidence for mechanisms and signaling pathways regulating the balance between renal NaCl reabsorption and K+ secretion, the two major effects of aldosterone. In particular, recent studies have demonstrated that mineralocorticoid receptor in intercalated cells is selectively regulated by phosphorylation, which prevents ligand binding and activation. Moreover, the ubiquitin ligase complex composed of Kelch-like 3 and Cullin 3 acts downstream of angiotensin II and plasma K+ alterations, regulating Na-Cl cotransporter independently of aldosterone in distal convoluted tubule cells. These and other effects are integrated to produce appropriate kidney responses in a high-aldosterone state, and are implicated in fluid and electrolyte disorders in humans. This review summarizes the current knowledge on mechanisms modulating mineralocorticoid receptor and its downstream effectors in the distal nephron.
© 2017 Society for Endocrinology.

Entities:  

Keywords:  KLHL3; angiotensin; phosphorylation; plasma K; ubiquitin proteasome system

Mesh:

Substances:

Year:  2017        PMID: 28341694     DOI: 10.1530/JOE-16-0669

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

Review 1.  Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects.

Authors:  Jonatan Barrera-Chimal; Ixchel Lima-Posada; George L Bakris; Frederic Jaisser
Journal:  Nat Rev Nephrol       Date:  2021-10-21       Impact factor: 28.314

Review 2.  Potassium homeostasis: sensors, mediators, and targets.

Authors:  Alicia A McDonough; Robert A Fenton
Journal:  Pflugers Arch       Date:  2022-06-21       Impact factor: 4.458

Review 3.  Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management.

Authors:  Shigeru Shibata; Shunya Uchida
Journal:  Ther Apher Dial       Date:  2021-08-31       Impact factor: 2.195

Review 4.  Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms.

Authors:  Johann Bauersachs; Achim Lother
Journal:  Kidney Int Suppl (2011)       Date:  2022-03-18

5.  Sex differences in solute transport along the nephrons: effects of Na+ transport inhibition.

Authors:  Rui Hu; Alicia A McDonough; Anita T Layton
Journal:  Am J Physiol Renal Physiol       Date:  2020-08-03

Review 6.  CD39-adenosinergic axis in renal pathophysiology and therapeutics.

Authors:  Bellamkonda K Kishore; Simon C Robson; Karen M Dwyer
Journal:  Purinergic Signal       Date:  2018-01-13       Impact factor: 3.765

Review 7.  Hyperkalemia in Diabetes Mellitus Setting.

Authors:  Kleber Goia-Nishide; Lucas Coregliano-Ring; Érika Bevilaqua Rangel
Journal:  Diseases       Date:  2022-03-28

8.  Cloning of nine glucocorticoid receptor isoforms from the slender African lungfish (Protopterus dolloi).

Authors:  Yoshinao Katsu; Shin Oana; Xiaozhi Lin; Susumu Hyodo; Laurent Bianchetti; Michael E Baker
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

9.  The mineralocorticoid receptor is essential for stress axis regulation in zebrafish larvae.

Authors:  Erin Faught; Mathilakath M Vijayan
Journal:  Sci Rep       Date:  2018-12-27       Impact factor: 4.379

10.  Characterization of pendrin in urinary extracellular vesicles in a rat model of aldosterone excess and in human primary aldosteronism.

Authors:  Fumika Ochiai-Homma; Emiko Kuribayashi-Okuma; Yuya Tsurutani; Kenichi Ishizawa; Wataru Fujii; Kohei Odajima; Mika Kawagoe; Yoshihiro Tomomitsu; Masataka Murakawa; Shinichiro Asakawa; Daigoro Hirohama; Michito Nagura; Shigeyuki Arai; Osamu Yamazaki; Yoshifuru Tamura; Yoshihide Fujigaki; Tetsuo Nishikawa; Shigeru Shibata
Journal:  Hypertens Res       Date:  2021-07-29       Impact factor: 3.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.